Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse.

Harrison DJ, Roberton VH, Vinh NN, Brooks SP, Dunnett SB, Rosser AE.

Cell Transplant. 2018 Feb;27(2):230-244. doi: 10.1177/0963689717744788.

2.

Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.

Schackel S, Pauly MC, Piroth T, Nikkhah G, Döbrössy MD.

Behav Brain Res. 2013 Nov 1;256:56-63. doi: 10.1016/j.bbr.2013.07.053. Epub 2013 Aug 3.

PMID:
23916743
3.
4.

Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.

Cisbani G, Saint-Pierre M, Cicchetti F.

Cell Transplant. 2014;23(10):1267-78. doi: 10.3727/096368913X668636. Epub 2013 Jun 17.

PMID:
23768945
5.

Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.

Johann V, Schiefer J, Sass C, Mey J, Brook G, Krüttgen A, Schlangen C, Bernreuther C, Schachner M, Dihné M, Kosinski CM.

Exp Brain Res. 2007 Mar;177(4):458-70. Epub 2006 Sep 30.

PMID:
17013619
7.
8.
9.
10.

Survival of iPSC-derived grafts within the striatum of immunodeficient mice: Importance of developmental stage of both transplant and host recipient.

Tom CM, Younesi S, Meer E, Bresee C, Godoy M, Mattis VB.

Exp Neurol. 2017 Nov;297:118-128. doi: 10.1016/j.expneurol.2017.07.018. Epub 2017 Jul 29.

PMID:
28760579
12.

Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.

Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, Bokla L, Landwehrmeyer GB, Volk B, Nikkhah G.

Neuroscience. 2009 May 19;160(3):661-75. doi: 10.1016/j.neuroscience.2009.02.035. Epub 2009 Feb 28.

PMID:
19254752
13.

Multitract microtransplantation increases the yield of DARPP-32-positive embryonic striatal cells in a rodent model of Huntington's disease.

Jiang W, Büchele F, Papazoglou A, Döbrössy M, Nikkhah G.

Cell Transplant. 2011;20(10):1515-27. doi: 10.3727/096368910X547435. Epub 2010 Dec 22.

PMID:
21176402
14.

A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions.

Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, Hevner RF, Born DE, Bird TD, Montine TJ.

Acta Neuropathol. 2009 Mar;117(3):329-38. doi: 10.1007/s00401-008-0465-0. Epub 2008 Dec 5.

15.

Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS.

Hurelbrink CB, Armstrong RJ, Dunnett SB, Rosser AE, Barker RA.

Eur J Neurosci. 2002 Apr;15(7):1255-66.

PMID:
11982636
16.

Neural transplantation in Huntington disease: long-term grafts in two patients.

Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, Montine TJ.

Neurology. 2007 Jun 12;68(24):2093-8.

PMID:
17562830
17.

Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.

Reddington AE, Rosser AE, Dunnett SB.

Front Cell Neurosci. 2014 Dec 2;8:398. doi: 10.3389/fncel.2014.00398. eCollection 2014. Review.

18.

Striatal graft projections are influenced by donor cell type and not the immunogenic background.

Kelly CM, Precious SV, Penketh R, Amso N, Dunnett SB, Rosser AE.

Brain. 2007 May;130(Pt 5):1317-29. Epub 2007 Mar 29.

PMID:
17395612
19.
20.

Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.

Cisbani G, Freeman TB, Soulet D, Saint-Pierre M, Gagnon D, Parent M, Hauser RA, Barker RA, Cicchetti F.

Brain. 2013 Feb;136(Pt 2):433-43. doi: 10.1093/brain/aws359. Epub 2013 Jan 31.

PMID:
23378216

Supplemental Content

Support Center